36022391_Infographic_Xevinapant_Trilynx_Design_Manuscript_v20.1.pdf (2.19 MB)
Download file

Infographic – Summary of the TrilynX phase 3 study design

Download (2.19 MB)
figure
posted on 17.02.2022, 11:05 authored by Jean Bourhis, Barbara Burtness, Lisa Francesca Licitra, Christopher M. Nutting, Jonathan D. Schoenfeld, Mokhtar Omar, Florilene Bouisset, Heidi Nauwelaerts, Yulia Urfer, Claudio Zanna, Ezra E.W. Cohen
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase 3 study design

Funding

Merck

History